Janet Woodcock
The legislation is pretty groundbreaking. The FD&C Act up until now has been practically silent, except for some of the...
The Implementer: How the Official Who Will Make FDAAA Work Views the New Law
The FDA Amendments Act transforms the drug safety system. In a recent address to the Food & Drug Law Institute, the acting head of the Center for Drug Evaluation & Research offered her view about what the law means and how the agency will make it work
More from Clinical Trials
More from R&D
• By
Broad participation by EU member states in a new pilot to test a unified procedure for evaluating applications for combined drug and IVD studies shows they recognize its value, says Monique Al, vice-chair of the Clinical Trials Coordination Group.
• By
Stefan Oelrich, the newly-announced president of European pharma industry federation EFPIA says the EU pharma reform is “not an improvement on the status quo” in its current form.
• By
Oncology trial sponsors in the UK are being invited to participate in a pilot that aims to tackle duplication and variation in pharmacy reviews, which are an important part of setting up clinical trials in the National Health Service.